Response to Letter to the Editor: "Central Precocious Puberty as a Presenting Sign of Nonclassical Congenital Adrenal Hyperplasia: Clinical Characteristics"

J Clin Endocrinol Metab. 2019 Dec 1;104(12):5808-5809. doi: 10.1210/jc.2019-01511.

Authors

Bar Neeman¹, Rachel Bello^{1

2}, Liora Lazar^{1

2}, Moshe Phillip^{1

2}, Liat de Vries^{1

2}

Affiliations

¹ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
² The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

PMID: 31322673
DOI: 10.1210/jc.2019-01511

No abstract available

Publication types

Comment

MeSH terms

17-alpha-Hydroxyprogesterone
Adrenal Hyperplasia, Congenital*
Adrenocorticotropic Hormone
Humans
Puberty, Precocious*

Substances

17-alpha-Hydroxyprogesterone
Adrenocorticotropic Hormone